Bank of America
MGX icon

Bank of America’s Metagenomi Therapeutics MGX Stock Holding History

Bank of America’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42
Closed -$68 – 6979
2025
Q4 		$68 Sell
42
-18,724
-100% -$40.5K ﹤0.01% 6901
2025
Q3 		$44.5K Buy
18,766
+15,682
+508% +$31.8K ﹤0.01% 6869
2025
Q2 		$4.56K Sell
3,084
-25,746
-89% -$40.3K ﹤0.01% 7312
2025
Q1 		$39.2K Buy
28,830
+7,717
+37% +$18.4K ﹤0.01% 6811
2024
Q4 		$76.2K Buy
21,113
+17,491
+483% +$42.2K ﹤0.01% 6517
2024
Q3 		$7.86K Buy
3,622
+327
+10% +$1.13K ﹤0.01% 6931
2024
Q2 		$13.4K Buy
3,295
+146
+5% +$1K ﹤0.01% 6833
2024
Q1 		$33.2K Buy
+3,149
New +$36.2K ﹤0.01% 6634

Other funds holding MGX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return